阵发性室上性心动过速药物转律临床疗效观察

目的分析观察阵发性室上性心动过速采取药物转律临床疗效. 方法选择我院 2013年3 月至 2015 年 6 月收治的阵发性室上性心动过速患者100 例,随机分成观察组和对照组,每组各50例.观察组患者采用可达龙进行治疗,对照组患者采用普罗帕酮药物进行治疗,治疗后对两组患者的转律成功率、转律时间、不良反应率进行对比.结果观察组患者的转律成功率、转律时间明显优于对照组（P〈0.05）,两组患者的不良反应率没有明显差异（P〉0.05）. 结论阵发性室上性心动过速应用可达龙进行转律疗效更佳.

ObjectiveTo observe the analysis of paroxysmal supraventricular tachycardia cardioversion take drugs clinical efficacy. Methodsin our hospital from March 2013 to June 2015 were treated with paroxysmal supraventricular tachycardia in 100 patients were randomly divided into observation group and control group, 50 cases in each. Observation group were treated with amiodarone treatment, the control group were treated with propafenone drug treatment, after treatment, the success rate of cardioversion two groups of patients, cardioversion time, adverse reaction rates were compared. ResultsThe success rate of cardioversion observed groups of patients, cardioversion time than the control group （P 〈0.05）, no significant difference （P adverse reaction rates of the two groups were〉 0.05）. ConclusionApplication of paroxysmal supraventricular tachycardia Amiodarone cardioversion performed better efficacy.